✦ LIBER ✦

Reactivation of chagas' disease during therapy of acute lymphocytic leukemia

✍ Scribed by Steve Kohl; Larry K. Pickering; Lawrence S. Frankel; Robert G. Yaeger

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 227 KB
Volume: 50
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820901)50:5<827::aid-cncr2820500503>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperbilirubinemia during induction ther

Hyperbilirubinemia during induction therapy of acute granulocytic leukemia

✍ Martin E. Katz; Peter A. Cassileth 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Monitoring of cytomegalovirus reactivati

Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia

✍ Monia Lunghi; Paola Riccomagno; Lorenzo De Paoli; Chiara Vendramin; Annarita Con 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Studies of T, B, and null lymphocytes du

Studies of T, B, and null lymphocytes during the course of acute lymphocytic leukemia

✍ Hie-Won L. Hann; W. Thomas London; Audrey E. Evans 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

Liver disease complicating the managemen

Liver disease complicating the management of acute leukemia during remission

✍ James O. Armitage; C. Patrick Burns; Thomas H. Kent 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Scrotal ulceration during induction ther

Scrotal ulceration during induction therapy of acute promyelocytic leukemia with ATRA

✍ Keechilat Pavithran; Rajalakshmi Arjun; Raman Aruna; Mathew Thomas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

Interferon treatment of chronic active h

Interferon treatment of chronic active hepatitis C during therapy of acute lymphoblastic leukemia

✍ Waldron, Peter 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views

Due to concerns that antineoplastic therapy produces prolonged decrease in immune function, interferon treatment of chronic active hepatitis C (CAHC) has been used only at one year or longer after the end of cancer therapy. We report the experience of an 11-year-old who developed symptomatic CAHC at